MiR-320a as a Potential Novel Circulating Biomarker of Arrhythmogenic CardioMyopathy
Abstract Diagnosis of Arrhythmogenic CardioMyopathy (ACM) is challenging and often late after disease onset. No circulating biomarkers are available to date. Given their involvement in several cardiovascular diseases, plasma microRNAs warranted investigation as potential non-invasive diagnostic tool...
Main Authors: | Elena Sommariva, Yuri D’Alessandra, Floriana Maria Farina, Michela Casella, Fabio Cattaneo, Valentina Catto, Mattia Chiesa, Ilaria Stadiotti, Silvia Brambilla, Antonio Dello Russo, Corrado Carbucicchio, Giulia Vettor, Daniela Riggio, Maria Teresa Sandri, Andrea Barbuti, Gianluca Vernillo, Manuela Muratori, Matteo Dal Ferro, Gianfranco Sinagra, Silvia Moimas, Mauro Giacca, Gualtiero Ivanoe Colombo, Giulio Pompilio, Claudio Tondo |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2017-07-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-017-05001-z |
Similar Items
-
Cell models of arrhythmogenic cardiomyopathy: advances and opportunities
by: Elena Sommariva, et al.
Published: (2017-07-01) -
Fibrosis in Arrhythmogenic Cardiomyopathy: The Phantom Thread in the Fibro-Adipose Tissue
by: Angela Serena Maione, et al.
Published: (2020-04-01) -
Excess TGF-β1 Drives Cardiac Mesenchymal Stromal Cells to a Pro-Fibrotic Commitment in Arrhythmogenic Cardiomyopathy
by: Angela Serena Maione, et al.
Published: (2021-03-01) -
Cardiac Biomarkers and Autoantibodies in Endurance Athletes: Potential Similarities with Arrhythmogenic Cardiomyopathy Pathogenic Mechanisms
by: Ilaria Stadiotti, et al.
Published: (2021-06-01) -
Cyclophilin A in Arrhythmogenic Cardiomyopathy Cardiac Remodeling
by: Erica Rurali, et al.
Published: (2019-05-01)